COMMUNIQUÉS West-GlobeNewswire

CorVel Announces Revenues and Earnings
20/05/2026
FORT WORTH, Texas, May 20, 2026 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter and fiscal year ended March 31, 2026. Revenues for the fiscal year ended March 31, 2026 were $ [...]
Avricore Health Announces $1.25 Million Financing
20/05/2026
VANCOUVER, British Columbia, May 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the " Company " or “ Avricore ”) announces a non-brokered private placement of up to 25,000,000 units ("Units") at a price [...]
Un essai clinique canadien sans précédent évalue des « comprimés de selles » pour améliorer l’immunothérapie du cancer du poumon
20/05/2026
Financée par la Société canadienne du cancer et la Fondation de la famille Weston, l’étude de recherche LUNA-2 sur les capsules de microbiome sera la plus vaste du genre au Canada LONDON, Ontario, 20 mai 2026 (GLOBE [...]
Disclosure of voting rights at AGM in Vistin Pharma ASA
20/05/2026
Oslo, Norway, 20 May 2026 In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 20th of May, the Company's Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total [...]
Winner Medical Breaks Ground on New Production Base in Vietnam to Serve Global Medical Supply Chains Through Local Manufacturing
20/05/2026
SHENZHEN, China, May 20, 2026 (GLOBE NEWSWIRE) -- Winner Medical has officially broken ground on its new manufacturing base in Hai Ha Industrial Park, Quang Ha Commune, Quang Ninh Province, Vietnam. With a total [...]
Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update
20/05/2026
Initiated a rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for tinlarebant for the treatment of Stargardt disease type 1 (STGD1); submission expected to be completed in [...]
IBA launches Rhodotron® LITE, a new low‑power X‑ray accelerator expanding access to sustainable irradiation solutions
20/05/2026
Louvain-la-Neuve, Belgium, May 20, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and electron beam and X-ray solutions for industrial advanced irradiation, [...]
IBA lance Rhodotron® LITE, un nouvel accélérateur à rayons X de faible puissance qui facilite l’accès à des solutions d’irradiation durables
20/05/2026
Louvain-la-Neuve, Belgique, le 20 mai 2026 – IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélérateurs de particules et des solutions de faisceaux d’électrons et à rayons X pour l’ [...]
Synendos Therapeutics Starts Phase 2 Trial in Generalized Anxiety Disorder
20/05/2026
Collaboration underway with Prof. Allan Young and King’s College, London First time a Selective Endocannabinoid Reuptake Inhibitor (SERI) molecule is dosed in a patient population BASEL, Switzerland, May 20, 2026 (GLOBE [...]
SERB Pharmaceuticals acquiert auprès de Hansa Biopharma les droits européens et MENA d’Idefirix® (imlifidase) pour 115 millions d’euros
20/05/2026
BRUXELLES, 20 mai 2026 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, ci-après « SERB », et Hansa Biopharma AB, ci-après « Hansa » (Nasdaq Stockholm : HNSA) annoncent la conclusion d’un accord portant sur l’acquisition, par [...]
Java Tide Critical Assessment: The Gelatin Ice Trick Before Bed Using the Java Tide Formula Recipe
20/05/2026
Java Tide Scam or Legit, Complaints, Side Effects, and Supplement Ingredients: Chicory Root Inulin, Resistant Starch, Akkermansia muciniphila, and Gut Support Largo, FL, May 19, 2026 (GLOBE NEWSWIRE) -- These statements [...]
Shiny Smile Veneers Claims Evaluated (2026 Consumer Report Update) Critical Complaints Investigated
20/05/2026
Dr. Dean's Dentist-Designed Custom Snap-On Veneers: At-Home Impressions, FDA-Approved Biocompatible Resin, 3-Year Warranty, and 60-Day Money-Back Guarantee Richardson, TX , May 19, 2026 (GLOBE NEWSWIRE) -- Results may [...]
SlimTide Claims Evaluated: The Baking Soda Water Shot Gelatin Trick for Losing Weight Naturally by Slim Tide
20/05/2026
Chicory Root Inulin, Resistant Starch, and Akkermansia Muciniphila Probiotic Blend for Gut Microbiome and Metabolic Support Explained Largo, FL, May 19, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated [...]
Resmed Announces Participation in the 46th Annual William Blair Growth Stock Conference
19/05/2026
SAN DIEGO, May 19, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chairman and chief executive officer, and Aaron Bloomer, chief financial officer, will attend the 46 th Annual [...]
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
19/05/2026
SPF-Infused Concealer Featuring Kleair™ , WHSPR™ , and Chromalüm™ Recognized Across Anti-Aging, Color Cosmetics, and Compromised Skin ROMEOVILLE, Ill., May 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc . (Nasdaq: SLSN) a [...]
Annovis Announces Launch of Proposed Public Offering of Common Stock and Accompanying Warrants
19/05/2026
MALVERN, Pa., May 19, 2026 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a Phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for [...]
RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum
19/05/2026
ALISO VIEJO, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., today announced plans to participate in the upcoming Stifel 2026 Virtual Ophthalmology Forum. Management is scheduled to participate in [...]
Suja Life to Report First Quarter 2026 Financial Results on June 9, 2026
19/05/2026
OCEANSIDE, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Suja Life, Inc. (NASDAQ: SUJA) (“Suja Life” or the “Company”), a leading better-for-you beverage company and maker of Suja Organic , Vive Organic , and Slice Soda , [...]
Ipsen announces late-breaking data from first head-to-head study comparing Dysport® and Botox® in adults with upper limb spasticity
19/05/2026
Phase IV head-to-head, double-blind trial comparing safety and efficacy met its primary and secondary endpoints The DIRECTION trial results show the safety profile for Dysport ® (abobotulinumtoxinA) was non-inferior to [...]

Pages